• Refine Query
  • Source
  • Publication year
  • to
  • Language
  • 6
  • 1
  • Tagged with
  • 8
  • 8
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • About
  • The Global ETD Search service is a free service for researchers to find electronic theses and dissertations. This service is provided by the Networked Digital Library of Theses and Dissertations.
    Our metadata is collected from universities around the world. If you manage a university/consortium/country archive and want to be added, details can be found on the NDLTD website.
1

Inhibitory Effect of Elastase on the Glomerular Capillary Basement Membrane Thickening of the Experimental Congenital Diabetic Mice (N.S.Y. Mice)

YASUDA, BUNJI, SASAKI, MAKOTO, KUNO, TSUNEJI, KOBAYASHI, KAIZO, KISHI, TSUNEKI, KAWANISHI, ATSUKO, SHIBATA, MASAO 03 1900 (has links)
No description available.
2

Impairment of Baroreflex Control of Heart Rate in Conscious Transgenic Mice of Type 1 Diabetes (OVE26)

Lin, Min, Harden, Scott W., Li, Lihua, Wurster, Robert D., Cheng, Zixi J. 15 January 2010 (has links)
Baroreflex control of heart rate (HR) is impaired in human type 1 diabetes mellitus. The goal of this study is to use a transgenic mouse model of type 1 diabetes (OVE26) to assess the diabetes-induced baroreflex impairment in the conscious state. OVE26 transgenic mice (which develop hyperglycemia within the first three weeks after birth due to the specific damage of beta cells) and normal control mice (FVB) 5-6 months of age were anesthetized, and the left femoral artery and both veins were catheterized. On the second day after surgery, baroreflex-mediated HR responses to arterial blood pressure (ABP) changes that were induced by separate microinfusion of phenylephrine (PE) and sodium nitroprusside (SNP) at different doses (0.03-0.4 μg/min) were measured in the conscious state. Compared with FVB control, we found that in OVE26 diabetic mice 1) mean ABP (MABP) and HR were decreased (p < 0.05). 2) PE-induced MABP increases were comparable to those in FVB mice (p > 0.05). 3) Baroreflex-mediated bradycardia was attenuated (p < 0.05). 4) SNP-induced MABP decreases was reduced (p < 0.05). 5) Baroreflex-mediated tachycardia was attenuated (p < 0.05). Since baroreflex control of HR in conscious OVE26 mice is impaired in a similar fashion to human diabetes mellitus, we suggest that OVE26 mice may provide a useful model to study the neural mechanisms of diabetes-induced baroreflex impairment.
3

Defining the barrier of split tolerance in allogeneic mixed chimerism

Al-Adra, David P. Unknown Date
No description available.
4

Vliv antidiabeticky působících látek na vývoj inzulínové rezistence a neurodegenerativních změn v myších modelech diabetu 2. typu / Impact of antidiabetic substances to development of insulin resistance and neurodegenerative changes in mouse models of type 2 diabetes

Mikulášková, Barbora January 2014 (has links)
Numerous epidemiological and experimental studies have shown that patients suffering from metabolic disorders such as type 2 diabetes mellitus (TDM2), insulin resistance or obesity are at a higher risk of cognitive functions impairment and developing Alzheimer's disease (AD). Impairment of insulin signalling in the brain could contribute to two pathological changes which leads to AD development that include insoluble senile plaques and neurofibrillary tangles, containing an abnormally hyperphosphorylated tau protein (Tau). This work is focused on investigating of insulin signaling in hippocampi in the brains of mice models of insulin resistence, impact of disturbed insulin signaling on hyperphosphorylation of Tau, and possible benefical efect of insulin sensitizing agents on insulin signaling and Tau phosphorylation in the hippocampi of diabetic mice. The first, we examined insulin signaling and phosphorylation of Tau in hippocampi in two mouse models of TDM2 - lipodystrofic A-ZIP F-1 mice and monosodium glutamate obese mice (MSG mice). We did not observe any changes in insulin signaling and Tau phosphorylation in hippocampi of A-ZIP F-1 mice compared to controls. In the hippocampi of MSG mice there was attenuated phosphorylation of kinases of insulin signalling including Ser9 of glycogen synthase...
5

Characterizing the Role Toll Like Receptor 3 (TLR3) Plays in Viral-Mediated Type 1 Diabetes in Female Non-Obese Diabetic (NOD) Mice

Benner, Sarah E. 04 June 2019 (has links)
No description available.
6

Cardiovascular protective effects of Lindera obtusiloba / Les effets de "Lindera obtusiloba" pour la protection cardiovasculaire

Lee, Jung-Ok 06 March 2013 (has links)
La dysfonction endothéliale est un problème majeur au niveau mondial du fait de son implication dans de nombreuses pathologies. Ainsi, la dysfonction endothéliale est considérée comme un facteur pronostique défavorable dans les maladies cardiovasculaires. Les principaux mécanismes impliqués dans la dysfonction endothéliale sont la réduction de la formation et/ou de la biodisponibilité du monoxyde d’azote (NO), et la présence d’un stress oxydant. Le but de ce travail était d’évaluer des traitements phytothérapeutiques pouvant prévenir et/ou améliorer la dysfonction endothéliale. Le criblage de plus de trois cent plantes en fonction de leur capacité à induire une relaxation vasculaire et une inhibition de la NADPH oxydase (données confidentielles) a conduit à s’intéresser à Lindera obtusiloba. Ensuite, la capacité d’un extrait alcoolique de Lindera obtusiloba (LOE) à améliorer in vitro et in vivo la dysfonction endothéliale en activant la eNOS et en réduisant le stress oxydant a été testée. En conclusion, ces travaux indiquent que LOE possède des effets vasoprotecteurs in vitro et in vivo dans plusieurs modèles expérimentaux comme l’hypertension artérielle induite par l’angiotensine II, le diabète de type 2, l’athérosclérose et la thrombose pulmonaire. Ces effets bénéfiques impliquent, au moins en partie, la stimulation de la formation endothéliale du NO, la réduction du stress oxydant vasculaire via l’inhibition de la NADPH oxydase et l’inhibition de l’agrégation plaquettaire. Ainsi, LOE pourrait être un excellent candidat pour la prévention et/ou le traitement phytothérapeutique des maladies cardiovasculaires associées à une dysfonction endothéliale. / Endothelial dysfunction is a major worldwide topic because it is an important component and risk factor of a number of common human diseases. Therefore, endothelial dysfunction is considered a hallmark for vascular diseases, and has also been shown to be predictive of future adverse cardiovascular events. The main characteristic is a reduced NO production and bioavailability, and an increased vascular oxidative stress. The goal of the present research was to find a candidate for cardiovascular protective herbal medicine for the treatment of endothelial dysfunction. Through measurement of changes in isometric tension of porcine coronary artery rings, Lindera obtusiloba was selected amongst three hundred plants. Thereafter, the aim of our research was to determine whether an ethanolic extract of L. obtusiloba stems (LOE) improves endothelial dysfunction via activation of endothelial nitric oxide synthase and reduction of oxidative stress oxidase in vitro and in several animal models of cardiovascular diseases, and, if so, to elucidate the underlying mechanism. Altogether, the present findings indicate that LOE has vasoprotective effects both in vitro and in vivo including the Ang II-induced hypertention in rats, a type 2 diabetic mice model, and an atherosclerotic mice model, and a thromboembolism mice model, which involve its ability to stimulate the formation of NO, to reduce oxidative stress in the arterial wall, and to inhibit platelet aggregation. In conclusion, our studies reveal that LOE might be an interesting candidate as a cardiovascular protective herbal medicine in pathologies with endothelial dysfunction.
7

Renal Consequences of Coxsackievirus Infection and Type 1 Diabetes in Non-obese Diabetic Mice

Walter, Debra L. 01 October 2018 (has links)
No description available.
8

Increased Bacterial Adherence and Decreased Bacterial Clearance in Urinary Tract Infections with Diabetes Mellitus

Ozer, Ahmet 23 August 2013 (has links)
No description available.

Page generated in 0.055 seconds